Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 06 2024 - 4:05PM
Business Wire
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global
biopharmaceutical company focused on developing differentiated
molecules and combination therapies for people with cancer,
announced that its management team will participate in a fireside
chat at the upcoming Goldman Sachs 45th Annual Global Healthcare
Conference in Miami Beach, FL. The fireside chat will take place on
Wednesday, June 12th, 2024 at 10:00am ET.
A live webcast of the fireside chat will be available by
visiting the “Investors & Media” section of the Arcus
Biosciences website at www.arcusbio.com. A replay will be available
following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical
company developing differentiated molecules and combination
medicines for people with cancer. In partnership with industry
collaborators, patients and physicians around the world, Arcus is
expediting the development of first- or best-in-class medicines
against well-characterized biological targets and pathways and
studying novel, biology-driven combinations that have the potential
to help people with cancer live longer. Founded in 2015, the
company has expedited the development of multiple investigational
medicines into clinical studies, including new combination
approaches that target TIGIT, PD-1, the adenosine axis (CD73 and
dual A2a/A2b receptor), HIF-2a, CD39 and AXL. For more information
about Arcus Biosciences’ clinical and preclinical programs, please
visit www.arcusbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240606990218/en/
Investor Inquiries Pia Eaves VP of Investor Relations
& Strategy (617) 459-2006 peaves@arcusbio.com
Media Inquiries Holli Kolkey VP of Corporate
Communications (650) 922-1269 hkolkey@arcusbio.com
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
From Aug 2023 to Aug 2024